NCT03788395View on ClinicalTrials.gov

The Use of an Innovative Device for Therapeutic Adherence in Pediatric Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions
Asthma
Interventions
DEVICE

Symbicort Turbohaler plus Turbo+

Symbicort Turbohaler (Budesonide and Formoterol Fumarate Dihydrate) plus Turbo+ for three months.

DRUG

Symbicort Turbohaler without Turbo+

Symbicort Turbohaler (Budesonide and Formoterol Fumarate Dihydrate) without Turbo+ for three months.

Trial Locations (1)

90146

Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council, Palermo

All Listed Sponsors
lead

Istituto per la Ricerca e l'Innovazione Biomedica

OTHER

NCT03788395 - The Use of an Innovative Device for Therapeutic Adherence in Pediatric Asthma | Biotech Hunter | Biotech Hunter